中文  |  ENGLISH
  • Home
  • About us
  • Our Services
  • Laws&Regulations
  • Contact us
  • Chinese
Announcements
Home >> Home >> Announcements
  • No.146:Announcement of Cessation - Levetiracetam 2011-7-6
  • No.145:Announcement of Acceptance - paliperidone palmitate 2011-7-6
  • No.144:Announcement of Cessation -desloratadine 2011-7-6
  • No.143:Announcement of Cessation -Salmeterol xinafoate/ Fluticasone propionate 2011-7-6
  • No.142:Announcement of Cessation -Salmeterol xinafoate/ Fluticasone propionate 2011-7-6
  • No.141:Announcement of Cessation -Imiquimod Cream2011-7-6
  • No.139:Announcement of Cessation -Voriconazole Injection 2011-7-6
  • No.138:Announcement of Cessation -Voriconazole Tablet 2011-7-6
  • No.137:Announcement of Cessation -EXEMESTANE 2011-7-6
  • No.136:Announcement of Cessation -Lanreotide Acetate 2011-7-6
  • No.135:Announcement of Cessation - lercanidipine hydrochloride 2011-7-6
  • No.134:Announcement of Cessation - Purified structured triglyceride Emulsion for2011-7-6
  • No.133:Announcement of Cessation - metoprolol succinate [2011-7-6
  • No.132:Announcement of Cessation - Ibandronic Acid 2011-7-6
  • No.131:Announcement of Cessation - Amrubicin Hydrochloride for Injection 2011-7-6
Totar 10 Pages  Current 1 Page  [ Home ]  [ Previous ]  [ Next ]  [Last]
Add:Room 1108, Office Building B, Maples International Business Center
No.32, Xizhimen North Street, Haidian District, Beijing 100082, P. R. China
Tel:010-82211895; 82211550   Fax:010-82211755   E-mail: huake@huake.com.cn   ICP:05015802
Copyright © Huake.com.cn, All Rights Reserved.